Drug policy in South Asia is based on a zero-tolerance approach with punitive legislation that leans heavily on incarceration for people involved in drug offences. Harm reduction and treatment services remain scarce and often of low quality. In the field of supply, crop eradication campaigns have been unable to curb opium production in the region.
Whilst WHO member states aim to eliminate hepatitis C by 2030, interviews with 'at risk' individuals suggest that insufficient awareness of the illness and a lack of health facilities act as barriers to these ambitious targets.
Harm reduction workers in Afghanistan face an unjust paradox: Despite providing key support for people who use drugs and people living with HIV, they are often excluded from the public health community.
This participatory workshop will offer a space for experienced campaigners in Asia to reflect on advocacy achievements, identify and prioritise pending challenges, and devise context-specific strategies for expanding the impact and reach of the Support. Don’t Punish campaign.
IDPC evaluates the impacts of drug policies implemented in Asia over the past decade, assessing progress made towards international and regional goals and concluding on the need to move away from the damaging drug-free approach.
IDPC outlines the key drug policy developments in India since the UNGASS Outcome Document was adopted in 2016, which highlights health and human rights concerns in relation to both drugs and drug policies.
The Harm Reduction & Drug Policy Advocacy Fellowship Programme aims to support the development of policy advocacy champions through mentoring and capacity building in the project countries (India, Vietnam, Indonesia, Cambodia, Thailand, Nepal and the Philippines).